Search hospitals > California > San Jose
Stanford Cancer Center South Bay
Claim this profileSan Jose, California 95124
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Recurrence
Conducts research for Squamous Cell Carcinoma
Conducts research for Leukemia
27 reported clinical trials
5 medical researchers
Summary
Stanford Cancer Center South Bay is a medical facility located in San Jose, California. This center is recognized for care of Breast Cancer, Cancer, Recurrence, Squamous Cell Carcinoma, Leukemia and other specialties. Stanford Cancer Center South Bay is involved with conducting 27 clinical trials across 54 conditions. There are 5 research doctors associated with this hospital, such as Irene Wapnir, MD, Melinda Telli, MD, Beth M. Beadle, and Hilary Bagshaw.Area of expertise
1Breast Cancer
ER positive
HER2 positive
HER2 negative
2Cancer
HER2 positive
p16 positive
ER negative
Top PIs
Irene Wapnir, MDStanford Cancer Institute Palo Alto1 year of reported clinical research
Studies Breast Cancer
Studies Recurrence
9 reported clinical trials
20 drugs studied
Melinda Telli, MDStanford Cancer Institute Palo Alto3 years of reported clinical research
Studies Breast Cancer
Studies Cancer
8 reported clinical trials
17 drugs studied
Beth M. BeadleStanford Cancer Institute Palo Alto2 years of reported clinical research
Studies Squamous Cell Carcinoma
Studies Cancer
2 reported clinical trials
5 drugs studied
Hilary BagshawStanford Cancer Institute Palo Alto6 years of reported clinical research
Studies Prostate Cancer
Studies Adenocarcinoma
2 reported clinical trials
14 drugs studied
Clinical Trials running at Stanford Cancer Center South Bay
Breast Cancer
Squamous Cell Carcinoma
Prostate Cancer
Cancer
Oral Squamous Cell Carcinoma
Recurrence
Lip and Oral Cavity Cancer
Ventral Hernia
Prostate Adenocarcinoma
Tumors
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Stanford Cancer Center South Bay?
Stanford Cancer Center South Bay is a medical facility located in San Jose, California. This center is recognized for care of Breast Cancer, Cancer, Recurrence, Squamous Cell Carcinoma, Leukemia and other specialties. Stanford Cancer Center South Bay is involved with conducting 27 clinical trials across 54 conditions. There are 5 research doctors associated with this hospital, such as Irene Wapnir, MD, Melinda Telli, MD, Beth M. Beadle, and Hilary Bagshaw.